Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
The classification of Orally Disintegrating Tablet includes Anti-Psychotics Drug, Anti-Epileptics Drug and others, and the proportion of Anti-Psychotics Drug in 2017 is about 16.6%, Anti-Psychotics drug class will be the reigning segment in terms of market revenue share throughout the forecast period, anticipated to hold about 20.3% revenue share of the global market by 2025 end. With a noteworthy 15.7% CAGR, this segment will retain its supremacy over other drug class segments during the eight-year period. Under by Disease Indication, the global market is segmented into Central Nervous System (CNS) Diseases, Gastrointestinal (GI) Diseases, Cardiovascular (CVS) Diseases and Others. CNS Diseases segment will hold maximum revenue share in the global market, and the consumption proportion is about 53.4% in 2017. and forecasts indicate a 57.2% market share for this segment by the end of the forecast period in 2025.North America is the largest consumption place, with a consumption market share nearly 40.5% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 31.6%, China is also an important sales region for the Orally Disintegrating Tablet.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Orally Disintegrating Tablet market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Orally Disintegrating Tablet market. Detailed analysis of key players, along with key growth strategies adopted by Orally Disintegrating Tablet industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Bristol-Myers Squibb
Conquer
GSK
Eli Lilly and Company
Otsuka
Johnson and Johnson
AstraZeneca
Teva
Mylan
Pfizer
Merck
By Type:
Anti-psychotics Drug
Anti-epileptics Drug
Other
By End-User:
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Orally Disintegrating Tablet Market
-
1.3 Market Segment by Type
-
1.3.1 China Orally Disintegrating Tablet Market Size and Growth Rate of Anti-psychotics Drug from 2016 to 2027
-
1.3.2 China Orally Disintegrating Tablet Market Size and Growth Rate of Anti-epileptics Drug from 2016 to 2027
-
1.3.3 China Orally Disintegrating Tablet Market Size and Growth Rate of Other from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Orally Disintegrating Tablet Market Size and Growth Rate of CNS Diseases from 2016 to 2027
-
1.4.2 China Orally Disintegrating Tablet Market Size and Growth Rate of Gastrointestinal Diseases from 2016 to 2027
-
1.4.3 China Orally Disintegrating Tablet Market Size and Growth Rate of CVS Diseases from 2016 to 2027
-
1.4.4 China Orally Disintegrating Tablet Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Orally Disintegrating Tablet Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Orally Disintegrating Tablet by Major Types
-
3.4.1 Market Size and Growth Rate of Anti-psychotics Drug
-
3.4.2 Market Size and Growth Rate of Anti-epileptics Drug
-
3.4.3 Market Size and Growth Rate of Other
4 Segmentation of Orally Disintegrating Tablet Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Orally Disintegrating Tablet by Major End-Users
-
4.4.1 Market Size and Growth Rate of Orally Disintegrating Tablet in CNS Diseases
-
4.4.2 Market Size and Growth Rate of Orally Disintegrating Tablet in Gastrointestinal Diseases
-
4.4.3 Market Size and Growth Rate of Orally Disintegrating Tablet in CVS Diseases
-
4.4.4 Market Size and Growth Rate of Orally Disintegrating Tablet in Other
5 Market Analysis by Regions
-
5.1 China Orally Disintegrating Tablet Production Analysis by Regions
-
5.2 China Orally Disintegrating Tablet Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Orally Disintegrating Tablet Landscape Analysis
-
6.1 North China Orally Disintegrating Tablet Landscape Analysis by Major Types
-
6.2 North China Orally Disintegrating Tablet Landscape Analysis by Major End-Users
7 Central China Orally Disintegrating Tablet Landscape Analysis
-
7.1 Central China Orally Disintegrating Tablet Landscape Analysis by Major Types
-
7.2 Central China Orally Disintegrating Tablet Landscape Analysis by Major End-Users
8 South China Orally Disintegrating Tablet Landscape Analysis
-
8.1 South China Orally Disintegrating Tablet Landscape Analysis by Major Types
-
8.2 South China Orally Disintegrating Tablet Landscape Analysis by Major End-Users
9 East China Orally Disintegrating Tablet Landscape Analysis
-
9.1 East China Orally Disintegrating Tablet Landscape Analysis by Major Types
-
9.2 East China Orally Disintegrating Tablet Landscape Analysis by Major End-Users
10 Northeast China Orally Disintegrating Tablet Landscape Analysis
-
10.1 Northeast China Orally Disintegrating Tablet Landscape Analysis by Major Types
-
10.2 Northeast China Orally Disintegrating Tablet Landscape Analysis by Major End-Users
11 Southwest China Orally Disintegrating Tablet Landscape Analysis
-
11.1 Southwest China Orally Disintegrating Tablet Landscape Analysis by Major Types
-
11.2 Southwest China Orally Disintegrating Tablet Landscape Analysis by Major End-Users
12 Northwest China Orally Disintegrating Tablet Landscape Analysis
-
12.1 Northwest China Orally Disintegrating Tablet Landscape Analysis by Major Types
-
12.2 Northwest China Orally Disintegrating Tablet Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Bristol-Myers Squibb
-
13.1.1 Bristol-Myers Squibb Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Conquer
-
13.2.1 Conquer Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 GSK
-
13.3.1 GSK Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Eli Lilly and Company
-
13.4.1 Eli Lilly and Company Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Otsuka
-
13.5.1 Otsuka Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Johnson and Johnson
-
13.6.1 Johnson and Johnson Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 AstraZeneca
-
13.7.1 AstraZeneca Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Teva
-
13.8.1 Teva Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Mylan
-
13.9.1 Mylan Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Pfizer
-
13.10.1 Pfizer Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Merck
-
13.11.1 Merck Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Orally Disintegrating Tablet Market Size and Growth Rate of Anti-psychotics Drug from 2016 to 2027
-
Figure China Orally Disintegrating Tablet Market Size and Growth Rate of Anti-epileptics Drug from 2016 to 2027
-
Figure China Orally Disintegrating Tablet Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Orally Disintegrating Tablet Market Size and Growth Rate of CNS Diseases from 2016 to 2027
-
Figure China Orally Disintegrating Tablet Market Size and Growth Rate of Gastrointestinal Diseases from 2016 to 2027
-
Figure China Orally Disintegrating Tablet Market Size and Growth Rate of CVS Diseases from 2016 to 2027
-
Figure China Orally Disintegrating Tablet Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Orally Disintegrating Tablet Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Orally Disintegrating Tablet Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Orally Disintegrating Tablet
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Orally Disintegrating Tablet by Different Types from 2016 to 2027
-
Table Consumption Share of Orally Disintegrating Tablet by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Anti-psychotics Drug
-
Figure Market Size and Growth Rate of Anti-epileptics Drug
-
Figure Market Size and Growth Rate of Other
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Orally Disintegrating Tablet by Different End-Users from 2016 to 2027
-
Table Consumption Share of Orally Disintegrating Tablet by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of CNS Diseases
-
Figure Market Size and Growth Rate of Gastrointestinal Diseases
-
Figure Market Size and Growth Rate of CVS Diseases
-
Figure Market Size and Growth Rate of Other
-
Table China Orally Disintegrating Tablet Production by Regions
-
Table China Orally Disintegrating Tablet Production Share by Regions
-
Figure China Orally Disintegrating Tablet Production Share by Regions in 2016
-
Figure China Orally Disintegrating Tablet Production Share by Regions in 2021
-
Figure China Orally Disintegrating Tablet Production Share by Regions in 2027
-
Table China Orally Disintegrating Tablet Consumption by Regions
-
Table China Orally Disintegrating Tablet Consumption Share by Regions
-
Figure China Orally Disintegrating Tablet Consumption Share by Regions in 2016
-
Figure China Orally Disintegrating Tablet Consumption Share by Regions in 2021
-
Figure China Orally Disintegrating Tablet Consumption Share by Regions in 2027
-
Table North China Orally Disintegrating Tablet Consumption by Types from 2016 to 2027
-
Table North China Orally Disintegrating Tablet Consumption Share by Types from 2016 to 2027
-
Figure North China Orally Disintegrating Tablet Consumption Share by Types in 2016
-
Figure North China Orally Disintegrating Tablet Consumption Share by Types in 2021
-
Figure North China Orally Disintegrating Tablet Consumption Share by Types in 2027
-
Table North China Orally Disintegrating Tablet Consumption by End-Users from 2016 to 2027
-
Table North China Orally Disintegrating Tablet Consumption Share by End-Users from 2016 to 2027
-
Figure North China Orally Disintegrating Tablet Consumption Share by End-Users in 2016
-
Figure North China Orally Disintegrating Tablet Consumption Share by End-Users in 2021
-
Figure North China Orally Disintegrating Tablet Consumption Share by End-Users in 2027
-
Table Central China Orally Disintegrating Tablet Consumption by Types from 2016 to 2027
-
Table Central China Orally Disintegrating Tablet Consumption Share by Types from 2016 to 2027
-
Figure Central China Orally Disintegrating Tablet Consumption Share by Types in 2016
-
Figure Central China Orally Disintegrating Tablet Consumption Share by Types in 2021
-
Figure Central China Orally Disintegrating Tablet Consumption Share by Types in 2027
-
Table Central China Orally Disintegrating Tablet Consumption by End-Users from 2016 to 2027
-
Table Central China Orally Disintegrating Tablet Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Orally Disintegrating Tablet Consumption Share by End-Users in 2016
-
Figure Central China Orally Disintegrating Tablet Consumption Share by End-Users in 2021
-
Figure Central China Orally Disintegrating Tablet Consumption Share by End-Users in 2027
-
Table South China Orally Disintegrating Tablet Consumption by Types from 2016 to 2027
-
Table South China Orally Disintegrating Tablet Consumption Share by Types from 2016 to 2027
-
Figure South China Orally Disintegrating Tablet Consumption Share by Types in 2016
-
Figure South China Orally Disintegrating Tablet Consumption Share by Types in 2021
-
Figure South China Orally Disintegrating Tablet Consumption Share by Types in 2027
-
Table South China Orally Disintegrating Tablet Consumption by End-Users from 2016 to 2027
-
Table South China Orally Disintegrating Tablet Consumption Share by End-Users from 2016 to 2027
-
Figure South China Orally Disintegrating Tablet Consumption Share by End-Users in 2016
-
Figure South China Orally Disintegrating Tablet Consumption Share by End-Users in 2021
-
Figure South China Orally Disintegrating Tablet Consumption Share by End-Users in 2027
-
Table East China Orally Disintegrating Tablet Consumption by Types from 2016 to 2027
-
Table East China Orally Disintegrating Tablet Consumption Share by Types from 2016 to 2027
-
Figure East China Orally Disintegrating Tablet Consumption Share by Types in 2016
-
Figure East China Orally Disintegrating Tablet Consumption Share by Types in 2021
-
Figure East China Orally Disintegrating Tablet Consumption Share by Types in 2027
-
Table East China Orally Disintegrating Tablet Consumption by End-Users from 2016 to 2027
-
Table East China Orally Disintegrating Tablet Consumption Share by End-Users from 2016 to 2027
-
Figure East China Orally Disintegrating Tablet Consumption Share by End-Users in 2016
-
Figure East China Orally Disintegrating Tablet Consumption Share by End-Users in 2021
-
Figure East China Orally Disintegrating Tablet Consumption Share by End-Users in 2027
-
Table Northeast China Orally Disintegrating Tablet Consumption by Types from 2016 to 2027
-
Table Northeast China Orally Disintegrating Tablet Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Orally Disintegrating Tablet Consumption Share by Types in 2016
-
Figure Northeast China Orally Disintegrating Tablet Consumption Share by Types in 2021
-
Figure Northeast China Orally Disintegrating Tablet Consumption Share by Types in 2027
-
Table Northeast China Orally Disintegrating Tablet Consumption by End-Users from 2016 to 2027
-
Table Northeast China Orally Disintegrating Tablet Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Orally Disintegrating Tablet Consumption Share by End-Users in 2016
-
Figure Northeast China Orally Disintegrating Tablet Consumption Share by End-Users in 2021
-
Figure Northeast China Orally Disintegrating Tablet Consumption Share by End-Users in 2027
-
Table Southwest China Orally Disintegrating Tablet Consumption by Types from 2016 to 2027
-
Table Southwest China Orally Disintegrating Tablet Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Orally Disintegrating Tablet Consumption Share by Types in 2016
-
Figure Southwest China Orally Disintegrating Tablet Consumption Share by Types in 2021
-
Figure Southwest China Orally Disintegrating Tablet Consumption Share by Types in 2027
-
Table Southwest China Orally Disintegrating Tablet Consumption by End-Users from 2016 to 2027
-
Table Southwest China Orally Disintegrating Tablet Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Orally Disintegrating Tablet Consumption Share by End-Users in 2016
-
Figure Southwest China Orally Disintegrating Tablet Consumption Share by End-Users in 2021
-
Figure Southwest China Orally Disintegrating Tablet Consumption Share by End-Users in 2027
-
Table Northwest China Orally Disintegrating Tablet Consumption by Types from 2016 to 2027
-
Table Northwest China Orally Disintegrating Tablet Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Orally Disintegrating Tablet Consumption Share by Types in 2016
-
Figure Northwest China Orally Disintegrating Tablet Consumption Share by Types in 2021
-
Figure Northwest China Orally Disintegrating Tablet Consumption Share by Types in 2027
-
Table Northwest China Orally Disintegrating Tablet Consumption by End-Users from 2016 to 2027
-
Table Northwest China Orally Disintegrating Tablet Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Orally Disintegrating Tablet Consumption Share by End-Users in 2016
-
Figure Northwest China Orally Disintegrating Tablet Consumption Share by End-Users in 2021
-
Figure Northwest China Orally Disintegrating Tablet Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of Conquer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Conquer
-
Figure Sales and Growth Rate Analysis of Conquer
-
Figure Revenue and Market Share Analysis of Conquer
-
Table Product and Service Introduction of Conquer
-
Table Company Profile and Development Status of GSK
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK
-
Figure Sales and Growth Rate Analysis of GSK
-
Figure Revenue and Market Share Analysis of GSK
-
Table Product and Service Introduction of GSK
-
Table Company Profile and Development Status of Eli Lilly and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
-
Figure Revenue and Market Share Analysis of Eli Lilly and Company
-
Table Product and Service Introduction of Eli Lilly and Company
-
Table Company Profile and Development Status of Otsuka
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Otsuka
-
Figure Sales and Growth Rate Analysis of Otsuka
-
Figure Revenue and Market Share Analysis of Otsuka
-
Table Product and Service Introduction of Otsuka
-
Table Company Profile and Development Status of Johnson and Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson and Johnson
-
Figure Sales and Growth Rate Analysis of Johnson and Johnson
-
Figure Revenue and Market Share Analysis of Johnson and Johnson
-
Table Product and Service Introduction of Johnson and Johnson
-
Table Company Profile and Development Status of AstraZeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca
-
Figure Sales and Growth Rate Analysis of AstraZeneca
-
Figure Revenue and Market Share Analysis of AstraZeneca
-
Table Product and Service Introduction of AstraZeneca
-
Table Company Profile and Development Status of Teva
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva
-
Figure Sales and Growth Rate Analysis of Teva
-
Figure Revenue and Market Share Analysis of Teva
-
Table Product and Service Introduction of Teva
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
